Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment

CompletedOBSERVATIONAL
Enrollment

490

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Schizophrenia
Trial Locations (17)

Unknown

Research Site, Changhua

Research Site, Changhua-Lugang

Research Site, Chiayi City

Research Site, Kaohsiung-Niosong

Research Site, Kaohsiung-Sanmin

Research Site, Kaohsiung-Yanchao

Research Site, Keelung

Research Site, Miaoli

Research Site, Miaoli-Toufen

Research Site, Taichung-Beitun

Research Site, Taichung-Shalu

Research Site, Taipei-Banciao

Research Site, Taipei-Datong

Research Site, Taipei-Shilin

Research Site, Taipei-Shipai

Research Site, Taipei-Xindian

Research Site, Taoyuan District

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY